AMR.Rmd
Note: values on this page will change with every website update since they are based on randomly created values and the page was written in R Markdown. However, the methodology remains unchanged. This page was generated on 02 June 2019.
For this tutorial, we will create fake demonstration data to work with.
You can skip to Cleaning the data if you already have your own data ready. If you start your analysis, try to make the structure of your data generally look like this:
date | patient_id | mo | AMX | CIP |
---|---|---|---|---|
2019-06-02 | abcd | Escherichia coli | S | S |
2019-06-02 | abcd | Escherichia coli | S | R |
2019-06-02 | efgh | Escherichia coli | R | S |
As with many uses in R, we need some additional packages for AMR analysis. Our package works closely together with the tidyverse packages dplyr
and ggplot2
by Dr Hadley Wickham. The tidyverse tremendously improves the way we conduct data science - it allows for a very natural way of writing syntaxes and creating beautiful plots in R.
Our AMR
package depends on these packages and even extends their use and functions.
We will create some fake example data to use for analysis. For antimicrobial resistance analysis, we need at least: a patient ID, name or code of a microorganism, a date and antimicrobial results (an antibiogram). It could also include a specimen type (e.g. to filter on blood or urine), the ward type (e.g. to filter on ICUs).
With additional columns (like a hospital name, the patients gender of even [well-defined] clinical properties) you can do a comparative analysis, as this tutorial will demonstrate too.
To start with patients, we need a unique list of patients.
The LETTERS
object is available in R - it’s a vector with 26 characters: A
to Z
. The patients
object we just created is now a vector of length 260, with values (patient IDs) varying from A1
to Z10
. Now we we also set the gender of our patients, by putting the ID and the gender in a table:
The first 135 patient IDs are now male, the other 125 are female.
Let’s pretend that our data consists of blood cultures isolates from 1 January 2010 until 1 January 2018.
This dates
object now contains all days in our date range.
For completeness, we can also add the hospital where the patients was admitted and we need to define valid antibmicrobial results for our randomisation:
Using the sample()
function, we can randomly select items from all objects we defined earlier. To let our fake data reflect reality a bit, we will also approximately define the probabilities of bacteria and the antibiotic results with the prob
parameter.
sample_size <- 20000
data <- data.frame(date = sample(dates, size = sample_size, replace = TRUE),
patient_id = sample(patients, size = sample_size, replace = TRUE),
hospital = sample(hospitals, size = sample_size, replace = TRUE,
prob = c(0.30, 0.35, 0.15, 0.20)),
bacteria = sample(bacteria, size = sample_size, replace = TRUE,
prob = c(0.50, 0.25, 0.15, 0.10)),
AMX = sample(ab_interpretations, size = sample_size, replace = TRUE,
prob = c(0.60, 0.05, 0.35)),
AMC = sample(ab_interpretations, size = sample_size, replace = TRUE,
prob = c(0.75, 0.10, 0.15)),
CIP = sample(ab_interpretations, size = sample_size, replace = TRUE,
prob = c(0.80, 0.00, 0.20)),
GEN = sample(ab_interpretations, size = sample_size, replace = TRUE,
prob = c(0.92, 0.00, 0.08))
)
Using the left_join()
function from the dplyr
package, we can ‘map’ the gender to the patient ID using the patients_table
object we created earlier:
The resulting data set contains 5,000 blood culture isolates. With the head()
function we can preview the first 6 values of this data set:
date | patient_id | hospital | bacteria | AMX | AMC | CIP | GEN | gender |
---|---|---|---|---|---|---|---|---|
2014-12-18 | S8 | Hospital D | Escherichia coli | S | R | S | S | F |
2010-05-29 | Z4 | Hospital C | Escherichia coli | S | S | S | S | F |
2015-11-20 | G6 | Hospital C | Escherichia coli | S | S | S | S | M |
2015-11-07 | Q10 | Hospital D | Escherichia coli | S | S | S | S | F |
2013-11-26 | P8 | Hospital B | Streptococcus pneumoniae | S | R | S | S | F |
2014-07-30 | L3 | Hospital B | Escherichia coli | R | S | S | S | M |
Now, let’s start the cleaning and the analysis!
Use the frequency table function freq()
to look specifically for unique values in any variable. For example, for the gender
variable:
# Frequency table of `gender` from a data.frame (20,000 x 9)
#
# Class: factor (numeric)
# Length: 20,000 (of which NA: 0 = 0.00%)
# Levels: 2: F, M
# Unique: 2
#
# Item Count Percent Cum. Count Cum. Percent
# --- ----- ------- -------- ----------- -------------
# 1 M 10,420 52.1% 10,420 52.1%
# 2 F 9,580 47.9% 20,000 100.0%
So, we can draw at least two conclusions immediately. From a data scientist perspective, the data looks clean: only values M
and F
. From a researcher perspective: there are slightly more men. Nothing we didn’t already know.
The data is already quite clean, but we still need to transform some variables. The bacteria
column now consists of text, and we want to add more variables based on microbial IDs later on. So, we will transform this column to valid IDs. The mutate()
function of the dplyr
package makes this really easy:
We also want to transform the antibiotics, because in real life data we don’t know if they are really clean. The as.rsi()
function ensures reliability and reproducibility in these kind of variables. The mutate_at()
will run the as.rsi()
function on defined variables:
Finally, we will apply EUCAST rules on our antimicrobial results. In Europe, most medical microbiological laboratories already apply these rules. Our package features their latest insights on intrinsic resistance and exceptional phenotypes. Moreover, the eucast_rules()
function can also apply additional rules, like forcing
Because the amoxicillin (column AMX
) and amoxicillin/clavulanic acid (column AMC
) in our data were generated randomly, some rows will undoubtedly contain AMX = S and AMC = R, which is technically impossible. The eucast_rules()
fixes this:
data <- eucast_rules(data, col_mo = "bacteria")
#
# Rules by the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
# http://eucast.org/
#
# EUCAST Clinical Breakpoints (v9.0, 2019)
# Aerococcus sanguinicola (no new changes)
# Aerococcus urinae (no new changes)
# Anaerobic Gram negatives (no new changes)
# Anaerobic Gram positives (no new changes)
# Campylobacter coli (no new changes)
# Campylobacter jejuni (no new changes)
# Enterobacteriales (Order) (no new changes)
# Enterococcus (no new changes)
# Haemophilus influenzae (no new changes)
# Kingella kingae (no new changes)
# Moraxella catarrhalis (no new changes)
# Pasteurella multocida (no new changes)
# Staphylococcus (no new changes)
# Streptococcus groups A, B, C, G (no new changes)
# Streptococcus pneumoniae (1421 new changes)
# Viridans group streptococci (no new changes)
#
# EUCAST Expert Rules, Intrinsic Resistance and Exceptional Phenotypes (v3.1, 2016)
# Table 01: Intrinsic resistance in Enterobacteriaceae (1367 new changes)
# Table 02: Intrinsic resistance in non-fermentative Gram-negative bacteria (no new changes)
# Table 03: Intrinsic resistance in other Gram-negative bacteria (no new changes)
# Table 04: Intrinsic resistance in Gram-positive bacteria (2632 new changes)
# Table 08: Interpretive rules for B-lactam agents and Gram-positive cocci (no new changes)
# Table 09: Interpretive rules for B-lactam agents and Gram-negative rods (no new changes)
# Table 11: Interpretive rules for macrolides, lincosamides, and streptogramins (no new changes)
# Table 12: Interpretive rules for aminoglycosides (no new changes)
# Table 13: Interpretive rules for quinolones (no new changes)
#
# Other rules
# Non-EUCAST: amoxicillin/clav acid = S where ampicillin = S (2233 new changes)
# Non-EUCAST: ampicillin = R where amoxicillin/clav acid = R (113 new changes)
# Non-EUCAST: piperacillin = R where piperacillin/tazobactam = R (no new changes)
# Non-EUCAST: piperacillin/tazobactam = S where piperacillin = S (no new changes)
# Non-EUCAST: trimethoprim = R where trimethoprim/sulfa = R (no new changes)
# Non-EUCAST: trimethoprim/sulfa = S where trimethoprim = S (no new changes)
#
# --------------------------------------------------------------------------
# EUCAST rules affected 6,458 out of 20,000 rows, making a total of 7,766 edits
# => added 0 test results
#
# => changed 7,766 test results
# - 106 test results changed from S to I
# - 4,695 test results changed from S to R
# - 1,068 test results changed from I to S
# - 323 test results changed from I to R
# - 1,556 test results changed from R to S
# - 18 test results changed from R to I
# --------------------------------------------------------------------------
#
# Use verbose = TRUE to get a data.frame with all specified edits instead.
Now that we have the microbial ID, we can add some taxonomic properties:
data <- data %>%
mutate(gramstain = mo_gramstain(bacteria),
genus = mo_genus(bacteria),
species = mo_species(bacteria))
We also need to know which isolates we can actually use for analysis.
To conduct an analysis of antimicrobial resistance, you must only include the first isolate of every patient per episode (Hindler et al., Clin Infect Dis. 2007). If you would not do this, you could easily get an overestimate or underestimate of the resistance of an antibiotic. Imagine that a patient was admitted with an MRSA and that it was found in 5 different blood cultures the following weeks (yes, some countries like the Netherlands have these blood drawing policies). The resistance percentage of oxacillin of all isolates would be overestimated, because you included this MRSA more than once. It would clearly be selection bias.
The Clinical and Laboratory Standards Institute (CLSI) appoints this as follows:
(…) When preparing a cumulative antibiogram to guide clinical decisions about empirical antimicrobial therapy of initial infections, only the first isolate of a given species per patient, per analysis period (eg, one year) should be included, irrespective of body site, antimicrobial susceptibility profile, or other phenotypical characteristics (eg, biotype). The first isolate is easily identified, and cumulative antimicrobial susceptibility test data prepared using the first isolate are generally comparable to cumulative antimicrobial susceptibility test data calculated by other methods, providing duplicate isolates are excluded.
M39-A4 Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, 4th Edition. CLSI, 2014. Chapter 6.4
This AMR
package includes this methodology with the first_isolate()
function. It adopts the episode of a year (can be changed by user) and it starts counting days after every selected isolate. This new variable can easily be added to our data:
data <- data %>%
mutate(first = first_isolate(.))
# NOTE: Using column `bacteria` as input for `col_mo`.
# NOTE: Using column `date` as input for `col_date`.
# NOTE: Using column `patient_id` as input for `col_patient_id`.
# => Found 5,665 first isolates (28.3% of total)
So only 28.3% is suitable for resistance analysis! We can now filter on it with the filter()
function, also from the dplyr
package:
For future use, the above two syntaxes can be shortened with the filter_first_isolate()
function:
We made a slight twist to the CLSI algorithm, to take into account the antimicrobial susceptibility profile. Imagine this data, sorted on date:
isolate | date | patient_id | bacteria | AMX | AMC | CIP | GEN | first |
---|---|---|---|---|---|---|---|---|
1 | 2010-01-18 | T2 | B_ESCHR_COL | S | S | S | S | TRUE |
2 | 2010-01-26 | T2 | B_ESCHR_COL | R | S | R | S | FALSE |
3 | 2010-02-26 | T2 | B_ESCHR_COL | I | S | S | S | FALSE |
4 | 2010-03-13 | T2 | B_ESCHR_COL | S | S | S | S | FALSE |
5 | 2010-08-18 | T2 | B_ESCHR_COL | R | S | S | S | FALSE |
6 | 2010-12-10 | T2 | B_ESCHR_COL | S | S | R | S | FALSE |
7 | 2011-05-02 | T2 | B_ESCHR_COL | S | S | R | S | TRUE |
8 | 2011-05-02 | T2 | B_ESCHR_COL | R | S | S | S | FALSE |
9 | 2011-05-15 | T2 | B_ESCHR_COL | S | S | S | S | FALSE |
10 | 2011-05-15 | T2 | B_ESCHR_COL | R | S | S | S | FALSE |
Only 2 isolates are marked as ‘first’ according to CLSI guideline. But when reviewing the antibiogram, it is obvious that some isolates are absolutely different strains and should be included too. This is why we weigh isolates, based on their antibiogram. The key_antibiotics()
function adds a vector with 18 key antibiotics: 6 broad spectrum ones, 6 small spectrum for Gram negatives and 6 small spectrum for Gram positives. These can be defined by the user.
If a column exists with a name like ‘key(…)ab’ the first_isolate()
function will automatically use it and determine the first weighted isolates. Mind the NOTEs in below output:
data <- data %>%
mutate(keyab = key_antibiotics(.)) %>%
mutate(first_weighted = first_isolate(.))
# NOTE: Using column `bacteria` as input for `col_mo`.
# NOTE: Using column `bacteria` as input for `col_mo`.
# NOTE: Using column `date` as input for `col_date`.
# NOTE: Using column `patient_id` as input for `col_patient_id`.
# NOTE: Using column `keyab` as input for `col_keyantibiotics`. Use col_keyantibiotics = FALSE to prevent this.
# [Criterion] Inclusion based on key antibiotics, ignoring I.
# => Found 15,064 first weighted isolates (75.3% of total)
isolate | date | patient_id | bacteria | AMX | AMC | CIP | GEN | first | first_weighted |
---|---|---|---|---|---|---|---|---|---|
1 | 2010-01-18 | T2 | B_ESCHR_COL | S | S | S | S | TRUE | TRUE |
2 | 2010-01-26 | T2 | B_ESCHR_COL | R | S | R | S | FALSE | TRUE |
3 | 2010-02-26 | T2 | B_ESCHR_COL | I | S | S | S | FALSE | TRUE |
4 | 2010-03-13 | T2 | B_ESCHR_COL | S | S | S | S | FALSE | FALSE |
5 | 2010-08-18 | T2 | B_ESCHR_COL | R | S | S | S | FALSE | TRUE |
6 | 2010-12-10 | T2 | B_ESCHR_COL | S | S | R | S | FALSE | TRUE |
7 | 2011-05-02 | T2 | B_ESCHR_COL | S | S | R | S | TRUE | TRUE |
8 | 2011-05-02 | T2 | B_ESCHR_COL | R | S | S | S | FALSE | TRUE |
9 | 2011-05-15 | T2 | B_ESCHR_COL | S | S | S | S | FALSE | TRUE |
10 | 2011-05-15 | T2 | B_ESCHR_COL | R | S | S | S | FALSE | TRUE |
Instead of 2, now 9 isolates are flagged. In total, 75.3% of all isolates are marked ‘first weighted’ - 47% more than when using the CLSI guideline. In real life, this novel algorithm will yield 5-10% more isolates than the classic CLSI guideline.
As with filter_first_isolate()
, there’s a shortcut for this new algorithm too:
So we end up with 15,064 isolates for analysis.
We can remove unneeded columns:
Now our data looks like:
date | patient_id | hospital | bacteria | AMX | AMC | CIP | GEN | gender | gramstain | genus | species | first_weighted | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 2015-11-20 | G6 | Hospital C | B_ESCHR_COL | S | S | S | S | M | Gram negative | Escherichia | coli | TRUE |
4 | 2015-11-07 | Q10 | Hospital D | B_ESCHR_COL | S | S | S | S | F | Gram negative | Escherichia | coli | TRUE |
5 | 2013-11-26 | P8 | Hospital B | B_STRPT_PNE | S | S | S | R | F | Gram positive | Streptococcus | pneumoniae | TRUE |
6 | 2014-07-30 | L3 | Hospital B | B_ESCHR_COL | R | S | S | S | M | Gram negative | Escherichia | coli | TRUE |
7 | 2016-04-08 | C7 | Hospital A | B_ESCHR_COL | R | S | R | S | M | Gram negative | Escherichia | coli | TRUE |
8 | 2010-02-28 | A8 | Hospital D | B_ESCHR_COL | S | S | S | S | M | Gram negative | Escherichia | coli | TRUE |
Time for the analysis!
You might want to start by getting an idea of how the data is distributed. It’s an important start, because it also decides how you will continue your analysis. Although this package contains a convenient function to make frequency tables, exploratory data analysis (EDA) is not the primary scope of this package. Use a package like DataExplorer
for that, or read the free online book Exploratory Data Analysis with R by Roger D. Peng.
To just get an idea how the species are distributed, create a frequency table with our freq()
function. We created the genus
and species
column earlier based on the microbial ID. With paste()
, we can concatenate them together.
The freq()
function can be used like the base R language was intended:
Or can be used like the dplyr
way, which is easier readable:
Frequency table of genus
and species
from a data.frame
(15,064 x 13)
Columns: 2
Length: 15,064 (of which NA: 0 = 0.00%)
Unique: 4
Shortest: 16
Longest: 24
Item | Count | Percent | Cum. Count | Cum. Percent | |
---|---|---|---|---|---|
1 | Escherichia coli | 7,474 | 49.6% | 7,474 | 49.6% |
2 | Staphylococcus aureus | 3,691 | 24.5% | 11,165 | 74.1% |
3 | Streptococcus pneumoniae | 2,238 | 14.9% | 13,403 | 89.0% |
4 | Klebsiella pneumoniae | 1,661 | 11.0% | 15,064 | 100.0% |
The functions portion_S()
, portion_SI()
, portion_I()
, portion_IR()
and portion_R()
can be used to determine the portion of a specific antimicrobial outcome. As per the EUCAST guideline of 2019, we calculate resistance as the portion of R (portion_R()
) and susceptibility as the portion of S and I (portion_SI()
). These functions can be used on their own:
Or can be used in conjuction with group_by()
and summarise()
, both from the dplyr
package:
hospital | amoxicillin |
---|---|
Hospital A | 0.4641785 |
Hospital B | 0.4697084 |
Hospital C | 0.4838129 |
Hospital D | 0.4796271 |
Of course it would be very convenient to know the number of isolates responsible for the percentages. For that purpose the n_rsi()
can be used, which works exactly like n_distinct()
from the dplyr
package. It counts all isolates available for every group (i.e. values S, I or R):
hospital | amoxicillin | available |
---|---|---|
Hospital A | 0.4641785 | 4662 |
Hospital B | 0.4697084 | 5282 |
Hospital C | 0.4838129 | 2224 |
Hospital D | 0.4796271 | 2896 |
These functions can also be used to get the portion of multiple antibiotics, to calculate empiric susceptibility of combination therapies very easily:
data_1st %>%
group_by(genus) %>%
summarise(amoxiclav = portion_SI(AMC),
gentamicin = portion_SI(GEN),
amoxiclav_genta = portion_SI(AMC, GEN))
genus | amoxiclav | gentamicin | amoxiclav_genta |
---|---|---|---|
Escherichia | 0.9211935 | 0.8898849 | 0.9933101 |
Klebsiella | 0.8169777 | 0.8832029 | 0.9843468 |
Staphylococcus | 0.9184503 | 0.9170956 | 0.9937686 |
Streptococcus | 0.6090259 | 0.0000000 | 0.6090259 |
To make a transition to the next part, let’s see how this difference could be plotted:
To show results in plots, most R users would nowadays use the ggplot2
package. This package lets you create plots in layers. You can read more about it on their website. A quick example would look like these syntaxes:
ggplot(data = a_data_set,
mapping = aes(x = year,
y = value)) +
geom_col() +
labs(title = "A title",
subtitle = "A subtitle",
x = "My X axis",
y = "My Y axis")
# or as short as:
ggplot(a_data_set) +
geom_bar(aes(year))
The AMR
package contains functions to extend this ggplot2
package, for example geom_rsi()
. It automatically transforms data with count_df()
or portion_df()
and show results in stacked bars. Its simplest and shortest example:
Omit the translate_ab = FALSE
to have the antibiotic codes (AMX, AMC, CIP, GEN) translated to official WHO names (amoxicillin, amoxicillin and betalactamase inhibitor, ciprofloxacin, gentamicin).
If we group on e.g. the genus
column and add some additional functions from our package, we can create this:
# group the data on `genus`
ggplot(data_1st %>% group_by(genus)) +
# create bars with genus on x axis
# it looks for variables with class `rsi`,
# of which we have 4 (earlier created with `as.rsi`)
geom_rsi(x = "genus") +
# split plots on antibiotic
facet_rsi(facet = "Antibiotic") +
# make R red, I yellow and S green
scale_rsi_colours() +
# show percentages on y axis
scale_y_percent(breaks = 0:4 * 25) +
# turn 90 degrees, to make it bars instead of columns
coord_flip() +
# add labels
labs(title = "Resistance per genus and antibiotic",
subtitle = "(this is fake data)") +
# and print genus in italic to follow our convention
# (is now y axis because we turned the plot)
theme(axis.text.y = element_text(face = "italic"))
To simplify this, we also created the ggplot_rsi()
function, which combines almost all above functions:
The next example uses the included septic_patients
, which is an anonymised data set containing 2,000 microbial blood culture isolates with their full antibiograms found in septic patients in 4 different hospitals in the Netherlands, between 2001 and 2017. It is true, genuine data. This data.frame
can be used to practice AMR analysis.
We will compare the resistance to fosfomycin (column FOS
) in hospital A and D. The input for the final fisher.test()
will be this:
A | D | |
---|---|---|
IR | 25 | 77 |
S | 24 | 33 |
We can transform the data and apply the test in only a couple of lines:
septic_patients %>%
filter(hospital_id %in% c("A", "D")) %>% # filter on only hospitals A and D
select(hospital_id, FOS) %>% # select the hospitals and fosfomycin
group_by(hospital_id) %>% # group on the hospitals
count_df(combine_IR = TRUE) %>% # count all isolates per group (hospital_id)
tidyr::spread(hospital_id, Value) %>% # transform output so A and D are columns
select(A, D) %>% # and select these only
as.matrix() %>% # transform to good old matrix for fisher.test()
fisher.test() # do Fisher's Exact Test
#
# Fisher's Exact Test for Count Data
#
# data: .
# p-value = 0.03104
# alternative hypothesis: true odds ratio is not equal to 1
# 95 percent confidence interval:
# 0.2111489 0.9485124
# sample estimates:
# odds ratio
# 0.4488318
As can be seen, the p value is 0.03, which means that the fosfomycin resistances found in hospital A and D are really different.